gMG clinical trials at UCSF
1 research study open to eligible people
Generalized myasthenia gravis (gMG) makes muscles weak and tired. UCSF is researching Ravulizumab to find out how it acts in children with gMG. The study looks at the medicine's safety, effects, and how it moves through the body.
Showing trials for
Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
open to all eligible people
The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
San Francisco, California and other locations
Our lead scientists for gMG research studies include Jonathan Strober.
Last updated: